|1.||Harrison, Jonathan S: 1 article (10/2014)|
|2.||Nguyen, Mai: 1 article (10/2014)|
|3.||Wang, Xuening: 1 article (10/2014)|
|4.||Kafka, Michael: 1 article (10/2014)|
|5.||Pesakhov, Stella: 1 article (10/2014)|
|6.||Gocek, Elzbieta: 1 article (10/2014)|
|7.||Weng, Ashley: 1 article (10/2014)|
|8.||Studzinski, George P: 1 article (10/2014)|
|9.||Danilenko, Michael: 1 article (10/2014)|
|10.||Gulick, Tod: 1 article (08/2014)|
|2.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/01/2014 - "Notably, the extracellular-signal-regulated kinase-5 inhibitor BIX02189 induces apoptosis in acute myeloid leukemia tumor cells without affecting T cells from healthy donors. "
10/01/2014 - "Therefore, we utilized acute myeloid leukemia (AML) cells in culture (HL60 and U937), to determine if ERK5 has a role in 1,25D-induced terminal differentiation which is distinct from the previously shown involvement of ERK1/2. We previously found that inhibition of kinase activity of ERK5 by specific pharmacological inhibitors BIX02189 or XMD8-92 results in higher expression of general myeloid marker CD11b, but a lower expression of the monocytic marker CD14. "
|3.||2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
|4.||U 0126 (UO 126)